Bio-Connect
FACS analysis of HepG2 cells using GTX60446 Apolipoprotein E antibody [1H4]. Green : Apolipoprotein E Purple : negative control
FACS analysis of HepG2 cells using GTX60446 Apolipoprotein E antibody [1H4]. Green : Apolipoprotein E Purple : negative control
FACS analysis of HepG2 cells using GTX60446 Apolipoprotein E antibody [1H4]. Green : Apolipoprotein E Purple : negative control

Apolipoprotein E antibody [1H4]

GTX60446
GeneTex
ApplicationsFlow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetAPOE
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Apolipoprotein E antibody [1H4]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1/500 - 1/2000. IHC-P: 1/200 - 1/1000. FACS: 1/200 - 1/400. ELISA: 1/10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    1H4
  • Conjugate
    Unconjugated
  • Gene ID348
  • Target name
    APOE
  • Target description
    apolipoprotein E
  • Target synonyms
    AD2, APO-E, ApoE4, LDLCQ5, LPG, apolipoprotein E, apolipoprotein E3
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP02649
  • Protein Name
    Apolipoprotein E
  • Scientific Description
    The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Sarhan MA, Abdel-Hakeem MS, Mason AL, et al. Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism. Sci Rep. 2017,7(1):2495. doi: 10.1038/s41598-017-02648-6
    Read this paper